Ralliant (NYSE:RAL) Posts Earnings Results, Beats Estimates By $0.08 EPS

Ralliant (NYSE:RAL) announced its quarterly earnings data on Tuesday. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.08, FiscalAI reports. The business had revenue of $534.60 million during the quarter. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Ralliant updated its FY 2026 guidance to 2.530-2.690 EPS and its Q2 2026 guidance to 0.580-0.640 EPS.

Here are the key takeaways from Ralliant’s conference call:

• Ralliant reported a strong Q1 2026 beat across the board, with revenue of $535 million up 11% year over year, adjusted EBITDA margin of 18.6%, and adjusted EPS of $0.57 all above the high end of guidance.
• The company raised full-year 2026 guidance after seeing stronger-than-expected demand, especially in Test and Measurement and defense, with full-year revenue now expected at $2.185 billion-$2.245 billion and adjusted EPS at $2.53-$2.69.
• Defense and Space remains a major growth driver, with over $1 billion in backlog spanning 40+ programs and management saying the business should stay in double-digit growth this year, supported by replenishment demand and modernization spending.
• Test and Measurement returned to growth with 9% organic revenue growth and its highest book-to-bill since 2022, helped by strong demand in communications and diversified electronics, while semiconductors remain temporarily pressured by lapping a large customer project.
• Management announced a new Enterprise Productivity Program targeting $50 million-$60 million of annualized savings by 2028, while also stepping up shareholder returns through a $500 million buyback authorization and plans for a $100 million accelerated share repurchase in Q2.

Ralliant Stock Up 14.0%

Ralliant stock traded up $6.93 during midday trading on Tuesday, reaching $56.49. The stock had a trading volume of 3,400,097 shares, compared to its average volume of 1,656,927. Ralliant has a 12 month low of $37.27 and a 12 month high of $60.14. The company has a market capitalization of $6.32 billion and a P/E ratio of 28.91. The company has a fifty day moving average price of $44.32 and a two-hundred day moving average price of $47.07. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, June 8th. Ralliant’s payout ratio is presently 10.20%.

Insider Buying and Selling

In related news, SVP Karen M. Bick sold 2,530 shares of the business’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the completion of the sale, the senior vice president directly owned 42,652 shares of the company’s stock, valued at $1,983,318. The trade was a 5.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Institutional Trading of Ralliant

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its position in Ralliant by 60.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,314,834 shares of the company’s stock valued at $54,669,000 after buying an additional 496,171 shares in the last quarter. Scarborough Advisors LLC bought a new stake in Ralliant in the 1st quarter valued at about $56,000. KBC Group NV increased its position in Ralliant by 0.7% in the 1st quarter. KBC Group NV now owns 125,583 shares of the company’s stock valued at $5,223,000 after buying an additional 882 shares in the last quarter. Swiss National Bank increased its position in Ralliant by 0.4% in the 1st quarter. Swiss National Bank now owns 223,200 shares of the company’s stock valued at $9,283,000 after buying an additional 900 shares in the last quarter. Finally, Twin Capital Management Inc. bought a new stake in Ralliant during the 1st quarter worth approximately $916,000.

Analyst Ratings Changes

A number of brokerages have recently issued reports on RAL. Citigroup dropped their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Zacks Research raised Ralliant from a “strong sell” rating to a “hold” rating in a research note on Monday, April 13th. Truist Financial dropped their price objective on Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Vertical Research raised Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective on the stock in a research note on Friday, February 6th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Ralliant in a research note on Monday, May 4th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $50.50.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.